Use of Chamomilla Recutita in Phlebitis
Phase 3
Completed
- Conditions
- Phlebitis
- Registration Number
- NCT00989599
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
To verify the efficacy of topical applications of Chamomilla recutita infusion for phlebitis treatment, before dose response curve study and pilot study.
- Detailed Description
The hypothesis adopted was that patients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita infusion for 20 minutes three times per day, would present a shorter phlebitis regression time in comparison with patients treated with a lukewarm water compress.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 123
Inclusion Criteria
- Subjects with cancer who had infusion phlebitis during the administration of intravenous chemotherapy peripheral under hospitalization.
Exclusion Criteria
- Report made by the subject of study, prior hypersensitivity reaction or presentation during the research, adverse reaction to chamomile or any plant of the family Asteraceae ou Compositae: margarida (Aster tripolium), crisântemo (Chrysanthemum leucanthemum), artemísia or isopo santo (Artemísia vulgaris), carpineira or ambrósia americana (Ambrosia artemisiifolia) and senécio (Senecio jacobaea L.);
- Prescription during the process of data collection, some kind of anti-inflammatory with systemic or topical activity where it was located phlebitis, and, upon the occurrence of bacterial phlebitis, had been prescribed topical or systemic antibiotic therapy;
- Refusal of the subject to participate in the study, regardless of the time.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method phlebitis regression time medium of 7 days
- Secondary Outcome Measures
Name Time Method palpable venous cord regression time 72 hours
Trial Locations
- Locations (1)
Hospital de Base do Distrito Federal
🇧🇷Brasília, Brasília/DF, Brazil
Hospital de Base do Distrito Federal🇧🇷Brasília, Brasília/DF, Brazil